These additional signals may also play a role in gastric carcinomas, given that WNT/APC/β-catenin pathway-activated mutations are not universally observed in CDX2-induced gastric cancers and are observed in lower frequency in the sub-set with SOX2-expression maintenance. This evidence concerns the gene CDX2 and gastric carcinoma.